ADP-ribosylation factor-dependent phospholipase D activation by VPAC receptors and a PAC(1) receptor splice variant.

The VPAC(1) and VPAC(2) receptors for vasoactive intestinal polypeptide and the PAC(1) receptor for pituitary adenylate cyclase-activating polypeptide are members of a subfamily of G protein-coupled receptors (GPCRs). We recently reported that phospholipase D (PLD) activation by members of the rhodopsin group of GPCRs occurs by at least two routes, one of which seems to involve the small G protein ADP-ribosylation factor (ARF) and its physical association with GPCRs. Here we report that rat VPAC and PAC(1) receptors can also stimulate PLD (albeit less potently than adenylate cyclase) in transfected cells and also in cells where they are natively expressed. PLD responses of the VPAC receptors and the hop1 spice variant of the PAC(1) receptor but not its null form are sensitive to brefeldin A (BFA), an inhibitor of GTP exchange at ARF. The presence of the hop1 cassette in the rat PAC(1) receptor facilitates PLD activation in the absence of marked changes in ligand binding, receptor internalization, and adenylate cyclase activation, with some reduction in phospholipase C activation. Both VPAC(2) and PAC(1-hop1) (but not PAC(1-null)) receptors were shown to associate with immunoprecipitates directed against native or epitope-tagged ARF. A chimeric construct of the VPAC(2) receptor body with intracellular loop 3 (i3) of the PAC(1-null) receptor mediated BFA-insensitive activation of PLD, whereas the response of the corresponding PAC(1-hop1) construct was BFA-sensitive. Motifs in i3 of the PAC(1-hop1) receptor may act as critical determinants of coupling to ARF-dependent PLD activation by contributing to the GPCR:ARF interface.

[1]  M. Johnson,et al.  Mechanisms of phospholipase C activation by the vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide type 2 receptor. , 2001, Endocrinology.

[2]  E. Lutz,et al.  Printed in U.S.A. Copyright © 2000 by The Endocrine Society Gonadotropin-Releasing Hormone Receptor Activation , 2000 .

[3]  M. Johnson,et al.  Domains determining agonist selectivity in chimaeric VIP2 (VPAC2)/PACAP (PAC1) receptors , 1999, British journal of pharmacology.

[4]  P. A. Friedman,et al.  Cell-specific signaling and structure-activity relations of parathyroid hormone analogs in mouse kidney cells. , 1999, Endocrinology.

[5]  M. Grossmann,et al.  G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.

[6]  D. Galson,et al.  Phospholipase D- and protein kinase C isoenzyme-dependent signal transduction pathways activated by the calcitonin receptor. , 1998, Endocrinology.

[7]  S. Sealfon,et al.  Rhodopsin-family receptors associate with small G proteins to activate phospholipase D , 1998, Nature.

[8]  M. Brann,et al.  Structure/function relationships of a G-protein coupling pocket formed by the third intracellular loop of the m5 muscarinic receptor. , 1998, Biochemistry.

[9]  C. Delporte,et al.  The pituitary adenylate cyclase activating polypeptide (PACAP I) and VIP (PACAP II VIP1) receptors stimulate inositol phosphate synthesis in transfected CHO cells through interaction with different G proteins. , 1997, Biochimica et biophysica acta.

[10]  J. Exton New Developments in Phospholipase D* , 1997, The Journal of Biological Chemistry.

[11]  D. Donnelly The arrangement of the transmembrane helices in the secretin receptor family of G‐protein‐coupled receptors , 1997, FEBS letters.

[12]  J. Wess G‐protein‐coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G‐protein recognition , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  A. Harmar,et al.  Phospholipase C Activation by VIP1 and VIP2 Receptors Expressed in COS 7 Cells Involves a Pertussis Toxin‐Sensitive Mechanism , 1996, Annals of the New York Academy of Sciences.

[14]  J. Bockaert,et al.  Alternative Splicing in the N-terminal Extracellular Domain of the Pituitary Adenylate Cyclase-activating Polypeptide (PACAP) Receptor Modulates Receptor Selectivity and Relative Potencies of PACAP-27 and PACAP-38 in Phospholipase C Activation* , 1996, The Journal of Biological Chemistry.

[15]  R. Neubig,et al.  Structural requirements for G(o) activation by receptor-derived peptides: activation and modulation domains of the alpha 2-adrenergic receptor i3c region. , 1996, Molecular pharmacology.

[16]  S. Wank,et al.  Cloning and Characterization of the Signal Transduction of Four Splice Variants of the Human Pituitary Adenylate Cyclase Activating Polypeptide Receptor , 1996, The Journal of Biological Chemistry.

[17]  S. Rawlings,et al.  Differential expression of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptor subtypes in clonal pituitary somatotrophs and gonadotrophs. , 1995, Endocrinology.

[18]  E. Borrelli,et al.  Alternative Splicing of the Dopamine D2 Receptor Directs Specificity of Coupling to G-proteins (*) , 1995, The Journal of Biological Chemistry.

[19]  S. Shioda,et al.  Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) and Its Receptors: Neuroendocrine and Endocrine Interaction , 1995, Frontiers in Neuroendocrinology.

[20]  R. Nissenson,et al.  The Cytoplasmic Tail of the G-protein-coupled Receptor for Parathyroid Hormone and Parathyroid Hormone-related Protein Contains Positive and Negative Signals for Endocytosis (*) , 1995, The Journal of Biological Chemistry.

[21]  M. Gershengorn,et al.  Inhibition of inositol phosphate second messenger formation by intracellular loop one of a human calcitonin receptor. Expression and mutational analysis of synthetic receptor genes. , 1994, The Journal of biological chemistry.

[22]  L. Slice,et al.  The conserved NPXnY motif present in the gastrin-releasing peptide receptor is not a general sequestration sequence. , 1994, The Journal of biological chemistry.

[23]  T. Harmar,et al.  Multiple receptors for PACAP and VIP. , 1994, Trends in pharmacological sciences.

[24]  C. McArdle,et al.  Effects of pituitary adenylate cyclase-activating polypeptide in the pituitary: activation of two signal transduction pathways in the gonadotrope-derived alpha T3-1 cell line. , 1994, Endocrinology.

[25]  S. Goldring,et al.  Receptors for secretin, calcitonin, parathyroid hormone (PTH)/PTH-related peptide, vasoactive intestinal peptide, glucagonlike peptide 1, growth hormone-releasing hormone, and glucagon belong to a newly discovered G-protein-linked receptor family , 1993, Trends in Endocrinology & Metabolism.

[26]  G. Fink,et al.  The VIP2 receptor: Molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide , 1993, FEBS letters.

[27]  J. Christophe,et al.  Cloning of a splice variant of the pituitary adenylate cyclase-activating polypeptide (PACAP) type I receptor. , 1993, Biochemical and biophysical research communications.

[28]  Laurent Journot,et al.  Differential signal transduction by five splice variants of the PACAP receptor , 1993, Nature.

[29]  G. Fink,et al.  Molecular cloning and expression of a cDNA encoding a receptor for pituitary adenylate cyclase activating polypeptide (PACAP) , 1993, FEBS letters.

[30]  R. Shigemoto,et al.  Molecular cloning and tissue distribution of a receptor for pituitary adenylate cyclase-activating polypeptide , 1993, Neuron.

[31]  A. Arimura,et al.  Molecular cloning and functional expression of rat cDNAs encoding the receptor for pituitary adenylate cyclase activating polypeptide (PACAP). , 1993, Biochemical and biophysical research communications.

[32]  S. Wank,et al.  Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[33]  I. Nishimoto,et al.  Amino acids 356–372 constitute a Gi‐activator sequence of the α2‐adrenergic receptor and have a Phe substitute in the G protein‐activator sequence motif , 1992, FEBS letters.

[34]  I. Nishimoto,et al.  Detection of G protein-activator regions in M4 subtype muscarinic, cholinergic, and alpha 2-adrenergic receptors based upon characteristics in primary structure. , 1992, The Journal of biological chemistry.

[35]  R. Shigemoto,et al.  Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide , 1992, Neuron.

[36]  Y. Sun,et al.  The 38-amino acid form of pituitary adenylate cyclase-activating polypeptide stimulates dual signaling cascades in PC12 cells and promotes neurite outgrowth. , 1992, The Journal of biological chemistry.

[37]  S. Swillens How to estimate the total receptor concentration when the specific radioactivity of the ligand is unknown. , 1992, Trends in pharmacological sciences.

[38]  W. C. Probst,et al.  Sequence alignment of the G-protein coupled receptor superfamily. , 1992, DNA and cell biology.

[39]  R. Pittner,et al.  Activation of membrane protein kinase C by glucagon and Ca(2+)-mobilizing hormones in cultured rat hepatocytes. Role of phosphatidylinositol and phosphatidylcholine hydrolysis. , 1991, The Biochemical journal.

[40]  G. Fink,et al.  Solubilization of a large molecular weight form of the rat LHRH receptor. , 1987, The Journal of endocrinology.